Patterson Companies, Inc. (0KGB.L)
USD 30.89
(-0.19%)
USD 30.89
(-0.19%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 2.96 Billion USD | 0.61% |
| 2023 | 2.87 Billion USD | 5.02% |
| 2022 | 2.74 Billion USD | -0.36% |
| 2021 | 2.75 Billion USD | 1.33% |
| 2020 | 2.71 Billion USD | -16.94% |
| 2019 | 3.26 Billion USD | -5.83% |
| 2018 | 3.47 Billion USD | -1.03% |
| 2017 | 3.5 Billion USD | -0.37% |
| 2016 | 3.52 Billion USD | 19.44% |
| 2015 | 2.94 Billion USD | 2.9% |
| 2014 | 2.86 Billion USD | 7.19% |
| 2013 | 2.67 Billion USD | -2.44% |
| 2012 | 2.73 Billion USD | 6.8% |
| 2011 | 2.56 Billion USD | 5.86% |
| 2010 | 2.42 Billion USD | 13.56% |
| 2009 | 2.13 Billion USD | 2.76% |
| 2008 | 2.07 Billion USD | 7.01% |
| 2007 | 1.94 Billion USD | 1.5% |
| 2006 | 1.91 Billion USD | 13.43% |
| 2005 | 1.68 Billion USD | 6.06% |
| 2004 | 1.58 Billion USD | 92.84% |
| 2003 | 823.97 Million USD | 14.7% |
| 2002 | 718.37 Million USD | 30.81% |
| 2001 | 549.18 Million USD | 21.51% |
| 2000 | 451.97 Million USD | 21.08% |
| 1999 | 373.3 Million USD | 17.98% |
| 1998 | 316.4 Million USD | 29.41% |
| 1997 | 244.5 Million USD | 20.56% |
| 1996 | 202.8 Million USD | 18.39% |
| 1995 | 171.3 Million USD | 25.77% |
| 1994 | 136.2 Million USD | 31.59% |
| 1993 | 103.5 Million USD | 37.45% |
| 1992 | 75.3 Million USD | 16.56% |
| 1991 | 64.6 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 2.93 Billion USD | 1.74% |
| 2024 FY | 2.96 Billion USD | 3.12% |
| 2024 Q1 | 2.88 Billion USD | 0.16% |
| 2024 Q2 | 2.88 Billion USD | 0.21% |
| 2024 Q4 | 2.96 Billion USD | 0.99% |
| 2023 Q3 | 2.94 Billion USD | 2.14% |
| 2023 Q4 | 2.87 Billion USD | -2.14% |
| 2023 Q1 | 2.75 Billion USD | 0.61% |
| 2023 FY | 2.87 Billion USD | 5.02% |
| 2023 Q2 | 2.88 Billion USD | 4.43% |
| 2022 Q3 | 2.86 Billion USD | -1.35% |
| 2022 Q2 | 2.9 Billion USD | 5.52% |
| 2022 Q1 | 2.75 Billion USD | -0.02% |
| 2022 FY | 2.74 Billion USD | -0.36% |
| 2022 Q4 | 2.74 Billion USD | -4.26% |
| 2021 Q1 | 2.64 Billion USD | -2.55% |
| 2021 Q2 | 2.78 Billion USD | 5.4% |
| 2021 Q4 | 2.75 Billion USD | -3.49% |
| 2021 FY | 2.75 Billion USD | 1.33% |
| 2021 Q3 | 2.85 Billion USD | 2.22% |
| 2020 Q2 | 3.43 Billion USD | 2.56% |
| 2020 Q1 | 3.34 Billion USD | 2.46% |
| 2020 Q3 | 3.51 Billion USD | 2.27% |
| 2020 Q4 | 2.71 Billion USD | -22.72% |
| 2020 FY | 2.71 Billion USD | -16.94% |
| 2019 Q1 | 3.28 Billion USD | -5.3% |
| 2019 FY | 3.26 Billion USD | -5.83% |
| 2019 Q3 | 3.32 Billion USD | -0.71% |
| 2019 Q4 | 3.26 Billion USD | -1.54% |
| 2019 Q2 | 3.34 Billion USD | 1.72% |
| 2018 Q4 | 3.47 Billion USD | -5.52% |
| 2018 Q2 | 3.52 Billion USD | 0.95% |
| 2018 Q1 | 3.49 Billion USD | -0.36% |
| 2018 FY | 3.47 Billion USD | -1.03% |
| 2018 Q3 | 3.67 Billion USD | 4.13% |
| 2017 Q1 | 3.49 Billion USD | -0.61% |
| 2017 FY | 3.5 Billion USD | -0.37% |
| 2017 Q4 | 3.5 Billion USD | -2.4% |
| 2017 Q3 | 3.59 Billion USD | 0.1% |
| 2017 Q2 | 3.59 Billion USD | 2.6% |
| 2016 Q2 | 3.45 Billion USD | -18.58% |
| 2016 Q1 | 4.23 Billion USD | 43.83% |
| 2016 FY | 3.52 Billion USD | 19.44% |
| 2016 Q4 | 3.52 Billion USD | -0.98% |
| 2016 Q3 | 3.55 Billion USD | 3.01% |
| 2015 FY | 2.94 Billion USD | 2.9% |
| 2015 Q4 | 2.94 Billion USD | 2.65% |
| 2015 Q1 | 2.89 Billion USD | 1.2% |
| 2015 Q2 | 2.85 Billion USD | -1.44% |
| 2015 Q3 | 2.87 Billion USD | 0.49% |
| 2014 Q1 | 2.76 Billion USD | 3.33% |
| 2014 Q2 | 2.94 Billion USD | 6.79% |
| 2014 Q3 | 2.97 Billion USD | 0.91% |
| 2014 FY | 2.86 Billion USD | 7.19% |
| 2014 Q4 | 2.86 Billion USD | -3.75% |
| 2013 Q3 | 2.63 Billion USD | 0.66% |
| 2013 Q2 | 2.62 Billion USD | -2.97% |
| 2013 Q1 | 2.7 Billion USD | -1.42% |
| 2013 Q4 | 2.67 Billion USD | 1.33% |
| 2013 FY | 2.67 Billion USD | -2.44% |
| 2012 FY | 2.73 Billion USD | 6.8% |
| 2012 Q3 | 2.66 Billion USD | 11.18% |
| 2012 Q4 | 2.73 Billion USD | 2.76% |
| 2012 Q2 | 2.39 Billion USD | -4.76% |
| 2012 Q1 | 2.51 Billion USD | -1.85% |
| 2011 Q1 | 2.44 Billion USD | 1.03% |
| 2011 Q4 | 2.56 Billion USD | 2.45% |
| 2011 Q3 | 2.5 Billion USD | -1.82% |
| 2011 FY | 2.56 Billion USD | 5.86% |
| 2011 Q2 | 2.55 Billion USD | 4.17% |
| 2010 Q1 | 2.24 Billion USD | 5.39% |
| 2010 FY | 2.42 Billion USD | 13.56% |
| 2010 Q4 | 2.42 Billion USD | 4.31% |
| 2010 Q3 | 2.32 Billion USD | 3.05% |
| 2010 Q2 | 2.25 Billion USD | 0.25% |
| 2009 Q2 | 2.11 Billion USD | -0.69% |
| 2009 FY | 2.13 Billion USD | 2.76% |
| 2009 Q3 | 2.09 Billion USD | -0.67% |
| 2009 Q4 | 2.13 Billion USD | 1.75% |
| 2009 Q1 | 2.12 Billion USD | 2.38% |
| 2008 FY | 2.07 Billion USD | 7.01% |
| 2008 Q1 | 1.99 Billion USD | 2.91% |
| 2008 Q2 | 2.07 Billion USD | 3.91% |
| 2008 Q3 | 1.92 Billion USD | -7.0% |
| 2008 Q4 | 2.07 Billion USD | 7.6% |
| 2007 Q4 | 1.94 Billion USD | 4.89% |
| 2007 FY | 1.94 Billion USD | 1.5% |
| 2007 Q1 | 1.95 Billion USD | 2.02% |
| 2007 Q2 | 1.86 Billion USD | -4.51% |
| 2007 Q3 | 1.84 Billion USD | -0.67% |
| 2006 Q1 | 1.71 Billion USD | 2.01% |
| 2006 Q2 | 1.78 Billion USD | 3.72% |
| 2006 Q3 | 1.82 Billion USD | 2.11% |
| 2006 Q4 | 1.91 Billion USD | 5.0% |
| 2006 FY | 1.91 Billion USD | 13.43% |
| 2005 Q2 | 1.65 Billion USD | 1.27% |
| 2005 FY | 1.68 Billion USD | 6.06% |
| 2005 Q4 | 1.68 Billion USD | -3.59% |
| 2005 Q3 | 1.74 Billion USD | 5.48% |
| 2005 Q1 | 1.63 Billion USD | 2.98% |
| 2004 Q1 | 881.61 Million USD | 6.99% |
| 2004 Q3 | 1.5 Billion USD | 5.55% |
| 2004 Q4 | 1.58 Billion USD | 5.65% |
| 2004 FY | 1.58 Billion USD | 92.84% |
| 2004 Q2 | 1.42 Billion USD | 61.62% |
| 2003 Q1 | 720.82 Million USD | 0.34% |
| 2003 FY | 823.97 Million USD | 14.7% |
| 2003 Q4 | 823.97 Million USD | 7.84% |
| 2003 Q3 | 764.09 Million USD | 3.68% |
| 2003 Q2 | 736.95 Million USD | 2.24% |
| 2002 Q2 | 606.7 Million USD | 0.85% |
| 2002 Q4 | 718.37 Million USD | 12.68% |
| 2002 Q3 | 637.55 Million USD | 5.09% |
| 2002 FY | 718.37 Million USD | 30.81% |
| 2002 Q1 | 601.58 Million USD | 9.54% |
| 2001 FY | 549.18 Million USD | 21.51% |
| 2001 Q4 | 549.18 Million USD | 6.45% |
| 2001 Q3 | 515.88 Million USD | 5.18% |
| 2001 Q1 | 475.58 Million USD | 5.22% |
| 2001 Q2 | 490.46 Million USD | 3.13% |
| 2000 Q1 | 382.6 Million USD | 2.49% |
| 2000 Q4 | 451.97 Million USD | 7.43% |
| 2000 FY | 451.97 Million USD | 21.08% |
| 2000 Q3 | 420.7 Million USD | 2.86% |
| 2000 Q2 | 409 Million USD | 6.9% |
| 1999 Q1 | 322 Million USD | 1.77% |
| 1999 Q4 | 373.3 Million USD | 8.55% |
| 1999 FY | 373.3 Million USD | 17.98% |
| 1999 Q2 | 323.8 Million USD | 0.56% |
| 1999 Q3 | 343.9 Million USD | 6.21% |
| 1998 Q3 | 280.3 Million USD | 3.78% |
| 1998 Q4 | 316.4 Million USD | 12.88% |
| 1998 FY | 316.4 Million USD | 29.41% |
| 1998 Q1 | 243.3 Million USD | -0.49% |
| 1998 Q2 | 270.1 Million USD | 11.02% |
| 1997 FY | 244.5 Million USD | 20.56% |
| 1997 Q2 | 228.4 Million USD | 14.26% |
| 1997 Q1 | 199.9 Million USD | -1.43% |
| 1997 Q4 | 244.5 Million USD | 1.03% |
| 1997 Q3 | 242 Million USD | 5.95% |
| 1996 Q4 | 202.8 Million USD | 4.75% |
| 1996 Q1 | 170.1 Million USD | -0.7% |
| 1996 Q2 | 172.2 Million USD | 1.23% |
| 1996 Q3 | 193.6 Million USD | 12.43% |
| 1996 FY | 202.8 Million USD | 18.39% |
| 1995 Q3 | 160.7 Million USD | 9.69% |
| 1995 Q4 | 171.3 Million USD | 6.6% |
| 1995 FY | 171.3 Million USD | 25.77% |
| 1995 Q1 | 133.6 Million USD | -1.91% |
| 1995 Q2 | 146.5 Million USD | 9.66% |
| 1994 Q3 | 138 Million USD | 12.1% |
| 1994 Q2 | 123.1 Million USD | 23.35% |
| 1994 Q4 | 136.2 Million USD | -1.3% |
| 1994 Q1 | 99.8 Million USD | -3.57% |
| 1994 FY | 136.2 Million USD | 31.59% |
| 1993 Q3 | 97.5 Million USD | 15.38% |
| 1993 Q4 | 103.5 Million USD | 6.15% |
| 1993 Q2 | 84.5 Million USD | 0.0% |
| 1993 FY | 103.5 Million USD | 37.45% |
| 1992 Q4 | 75.3 Million USD | 0.0% |
| 1992 FY | 75.3 Million USD | 16.56% |
| 1991 FY | 64.6 Million USD | 0.0% |
| 1991 Q4 | 64.6 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Phreesia, Inc. | 371.08 Million USD | -700.103% |
| Accuray Incorporated | 468.62 Million USD | -533.566% |
| Align Technology, Inc. | 6.08 Billion USD | 51.198% |
| Elevance Health Inc. | 108.92 Billion USD | 97.274% |
| AxoGen, Inc. | 196.82 Million USD | -1408.463% |
| Boston Scientific Corporation | 35.13 Billion USD | 91.55% |
| CVS Health Corporation | 249.72 Billion USD | 98.811% |
| Cardinal Health, Inc. | 45.12 Billion USD | 93.42% |
| Centene Corporation | 84.64 Billion USD | 96.492% |
| DaVita Inc. | 17.61 Billion USD | 83.149% |
| HCA Healthcare, Inc. | 56.21 Billion USD | 94.718% |
| Hologic, Inc. | 9.15 Billion USD | 67.572% |
| Humana Inc. | 47.06 Billion USD | 93.692% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | 8.922% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | 82.248% |
| Masimo Corporation | 3.04 Billion USD | 2.382% |
| McKesson Corporation | 67.44 Billion USD | 95.598% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | 78.826% |
| ResMed Inc. | 6.87 Billion USD | 56.797% |
| Henry Schein, Inc. | 10.57 Billion USD | 71.918% |
| Teladoc Health, Inc. | 4.39 Billion USD | 32.404% |
| Universal Health Services, Inc. | 14.35 Billion USD | 79.32% |
| Veeva Systems Inc. | 5.91 Billion USD | 49.77% |
| Baxter International Inc. | 28.27 Billion USD | 89.5% |
| Becton, Dickinson and Company | 52.78 Billion USD | 94.375% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 80.772% |
| Danaher Corporation | 84.48 Billion USD | 96.486% |
| Stryker Corporation | 39.91 Billion USD | 92.561% |
| Medtronic plc | 89.98 Billion USD | 96.7% |